Clinical Trials Directory

Trials / Completed

CompletedNCT01353092

Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression

PEMF Treatment in Patients With Treatment Resistant Depression in On-going Antidepressant Drug Therapy. A Randomized, Double-blind, Clinically Controlled, Dose-response PEMF Trial for a Duration of Eight Weeks

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Hillerod Hospital, Denmark · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In this study patients with treatment resistant depression, as defined by Harold Sackeim, is subjected to daily sessions, for eight weeks, with Pulsating ElectroMagnetive Treatment (PEMF). Treatment is given two times a day, in the morning and in the afternoon. Patients are randomized into two groups. In group A patients receive active treatment both morning and afternoon. In group B patients receive one sham and one active treatment. The study is double-blind as neither the assessors or patients are aware of treatment allocation. Each session lasts 30 minutes. Patients are psychometrically assessed weekly for depression severity and side effect. After this intervention period patients are followed for further three weeks without PEMF treatment. Patients are on unchanged medication for the whole of the study period.

Conditions

Interventions

TypeNameDescription
DEVICERe5 Pulsating ElectroMagnetic FieldsRe5 Treatment Helmet using Pulsating ElectroMagnetic Fields (PEMF): 30 minutes of active PEMF therapy in the morning and 30 minutes of active PEMF therapy in the afternoon
DEVICERe5 Pulsating ElectroMagnetic Fields (PEMF)Re5 Treatment Helmet using Pulsating ElectroMagnetic Fields (PEMF): 30 minutes of sham therapy and 30 minutes of active therapy (morning or afternoon)

Timeline

Start date
2011-04-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-05-12
Last updated
2015-08-26

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01353092. Inclusion in this directory is not an endorsement.